Iridex (IRIX) Amortizatization of Intangibles (2024 - 2025)

Iridex (IRIX) posted quarterly Amortizatization of Intangibles of -$58000.0 for Q1 2025, up 33.33% quarter-over-quarter from -$87000.0 in Q4 2024.

Iridex (IRIX) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

Iridex's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at -$58000.0 for Q1 2025.

In Q1 2025, Amortizatization of Intangibles changed N/A year-over-year to -$58000.0; the TTM figure through Jan 2026 stood at -$58000.0 (up 60.27% YoY), while the FY2026 annual figure was -$58000.0, up 60.27% from the prior year.
Amortizatization of Intangibles for Q1 2025 stood at -$58000.0, up from -$87000.0 in the prior quarter.
The five-year high for Amortizatization of Intangibles was -$58000.0 in Q1 2025, with the low at -$87000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Abbott Laboratories	199.57 Bn	193.97 Bn	7.27 Bn	-
2	Stryker	127.25 Bn	123.77 Bn	4.50 Bn	-
3	Medtronic	118.81 Bn	109.59 Bn	6.41 Bn	-
4	Boston Scientific	73.35 Bn	72.81 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn	6.60 Mn
6	Dexcom	34.28 Bn	32.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.75 Bn	31.64 Bn	2.18 Bn	-
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	-
9	Steris	23.03 Bn	22.55 Bn	684.20 Mn	-
10	Iridex	13.34 Mn	8.66 Mn	4.30 Mn	276,000.00

Download Data